Literature DB >> 14581557

Generation of a recombinant cytomegalovirus for expression of a hantavirus glycoprotein.

Albert A Rizvanov1, Albert G M van Geelen, Sergey Morzunov, Elmer W Otteson, Charlotte Bohlman, Gregory S Pari, Stephen C St Jeor.   

Abstract

A cytomegalovirus (CMV) was isolated from its natural host, Peromyscus maniculatus, and was designated Peromyscus CMV (PCMV). A recombinant PCMV was constructed that contained Sin Nombre virus glycoprotein G1 (SNV-G1) fused in frame to the enhanced green fluorescent protein (EGFP) gene inserted into a site homologous to the human CMV UL33 (P33) gene. The recombinant CMV was used for expression and immunization of deer mice against SNV-G1. The results of the study indicate that P. maniculatus could be infected with as few as 10 virus particles of recombinant virus. Challenge of P. maniculatus with either recombinant or wild-type PCMV produced no overt pathology in infected animals. P. maniculatus immunized with recombinant virus developed an antibody response to SNV and EGFP. When rechallenged with recombinant virus, animals exhibited an anamnestic response against SNV. Interestingly, a preexisting immune response against PCMV did not prevent reinfection with recombinant PCMV.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14581557      PMCID: PMC254267          DOI: 10.1128/jvi.77.22.12203-12210.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Absence of infection in a neonate after possible exposure to sin nombre hantavirus in breast milk.

Authors:  R K Pai; M Bharadwaj; H Levy; G Overturf; D Goade; I A Wortman; R Nofchissey; B Hjelle
Journal:  Clin Infect Dis       Date:  1999-12       Impact factor: 9.079

2.  Development of a cytomegalovirus vector for somatic gene therapy.

Authors:  E Borst; M Messerle
Journal:  Bone Marrow Transplant       Date:  2000-05       Impact factor: 5.483

3.  Characterization of glycoproteins of viruses causing hemorrhagic fever with renal syndrome (HFRS) using monoclonal antibodies.

Authors:  J R Dantas; Y Okuno; H Asada; M Tamura; M Takahashi; O Tanishita; Y Takahashi; T Kurata; K Yamanishi
Journal:  Virology       Date:  1986-06       Impact factor: 3.616

4.  Insertion and deletion mutagenesis of the human cytomegalovirus genome.

Authors:  R R Spaete; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

5.  Phage-displayed peptides mimicking the discontinuous neutralization sites of puumala Hantavirus envelope glycoproteins.

Authors:  T Heiskanen; A Lundkvist; R Soliymani; E Koivunen; A Vaheri; H Lankinen
Journal:  Virology       Date:  1999-09-30       Impact factor: 3.616

6.  Ultrastructure of a rat cytomegalovirus.

Authors:  I K Berezesky; P M Grimley; S A Tyrrell; A S Rabson
Journal:  Exp Mol Pathol       Date:  1971-06       Impact factor: 3.362

7.  Human cytomegalovirus. Studies on the mechanism of viral cytopathology and inclusion body formation.

Authors:  R M McAllister; J E Filbert; C R Goodheart
Journal:  Proc Soc Exp Biol Med       Date:  1967-03

8.  Role of maternal antibody in natural infection of Peromyscus maniculatus with Sin Nombre virus.

Authors:  M K Borucki; J D Boone; J E Rowe; M C Bohlman; E A Kuhn; R DeBaca; S C St Jeor
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

9.  Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2.

Authors:  K Tsukamoto; C Kojima; Y Komori; N Tanimura; M Mase; S Yamaguchi
Journal:  Virology       Date:  1999-05-10       Impact factor: 3.616

10.  Mammalian growth-associated H1 histone kinase: a homolog of cdc2+/CDC28 protein kinases controlling mitotic entry in yeast and frog cells.

Authors:  T A Langan; J Gautier; M Lohka; R Hollingsworth; S Moreno; P Nurse; J Maller; R A Sclafani
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

View more
  13 in total

1.  Eradicating infectious disease using weakly transmissible vaccines.

Authors:  Scott L Nuismer; Benjamin M Althouse; Ryan May; James J Bull; Sean P Stromberg; Rustom Antia
Journal:  Proc Biol Sci       Date:  2016-10-26       Impact factor: 5.349

Review 2.  Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.

Authors:  John J Suschak; Connie S Schmaljohn
Journal:  Hum Vaccin Immunother       Date:  2019-10-07       Impact factor: 3.452

3.  Absence of frequent herpesvirus transmission in a nonhuman primate predator-prey system in the wild.

Authors:  Sripriya Murthy; Emmanuel Couacy-Hymann; Sonja Metzger; Kathrin Nowak; Helene De Nys; Christophe Boesch; Roman Wittig; Michael A Jarvis; Fabian H Leendertz; Bernhard Ehlers
Journal:  J Virol       Date:  2013-07-24       Impact factor: 5.103

Review 4.  Vaccine vectors: the bright side of cytomegalovirus.

Authors:  Andrea C Méndez; Cristina Rodríguez-Rojas; Margarita Del Val
Journal:  Med Microbiol Immunol       Date:  2019-03-21       Impact factor: 3.402

5.  The impact of genome length on replication and genome stability of the herpesvirus guinea pig cytomegalovirus.

Authors:  Xiaohong Cui; Alistair McGregor; Mark R Schleiss; Michael A McVoy
Journal:  Virology       Date:  2009-01-26       Impact factor: 3.616

6.  Identification of novel rodent herpesviruses, including the first gammaherpesvirus of Mus musculus.

Authors:  Bernhard Ehlers; Judit Küchler; Nezlisah Yasmum; Güzin Dural; Sebastian Voigt; Jonas Schmidt-Chanasit; Thomas Jäkel; Franz-Rainer Matuschka; Dania Richter; Sandra Essbauer; David J Hughes; Candice Summers; Malcolm Bennett; James P Stewart; Rainer G Ulrich
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

7.  Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection.

Authors:  Andrea Marzi; Aisling A Murphy; Friederike Feldmann; Christopher J Parkins; Elaine Haddock; Patrick W Hanley; Matthew J Emery; Flora Engelmann; Ilhem Messaoudi; Heinz Feldmann; Michael A Jarvis
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

8.  A little goes a long way: Weak vaccine transmission facilitates oral vaccination campaigns against zoonotic pathogens.

Authors:  Andrew J Basinski; Scott L Nuismer; Christopher H Remien
Journal:  PLoS Negl Trop Dis       Date:  2019-03-08

Review 9.  Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses.

Authors:  Joseph W Golden; Christopher D Hammerbeck; Eric M Mucker; Rebecca L Brocato
Journal:  Biomed Res Int       Date:  2015-07-21       Impact factor: 3.411

Review 10.  Self-disseminating vaccines for emerging infectious diseases.

Authors:  Aisling A Murphy; Alec J Redwood; Michael A Jarvis
Journal:  Expert Rev Vaccines       Date:  2015-11-02       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.